BIOMAT Database Logo BIOMAT Database Logo

Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents. 2017

Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Department of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt.

A new series of pyrazolo[1,5-c]pyrimidines were synthesized by different hybridization strategies. All structures were confirmed by IR, 1H, 13C, 1H-13C heteronuclear multiple-quantum correlation (HMQC) spectra and microanalysis. They were evaluated for their in vitro antileishmanial activity against miltefosine and amphotericin B deoxycholate as reference drugs. The most active compounds 2a and 9a demonstrated superior potencies to miltefosine by ten- and six-fold, respectively, for the promastigote form, and by 5.5-fold for the amastigote form. Their binding scenario to Leishmania major pteridine reductase was rationalized by docking experiments. In addition, all compounds were safe for the experimental animals orally up to 150 mg/kg and parenterally up to 75 mg/kg. This study provides novel chemotype class for antileishmanial activity. [Formula: see text].

UI MeSH Term Description Entries
D010767 Phosphorylcholine Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction. Choline Chloride Dihydrogen Phosphate,Choline Phosphate Chloride,Phosphorylcholine Chloride,Choline Phosphate,Phosphocholine,Chloride, Choline Phosphate,Chloride, Phosphorylcholine,Phosphate Chloride, Choline,Phosphate, Choline
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003840 Deoxycholic Acid A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Deoxycholate,Desoxycholic Acid,Kybella,Choleic Acid,Deoxycholic Acid, 12beta-Isomer,Deoxycholic Acid, 3beta-Isomer,Deoxycholic Acid, 5alpha-Isomer,Deoxycholic Acid, Disodium Salt,Deoxycholic Acid, Magnesium (2:1) Salt,Deoxycholic Acid, Monoammonium Salt,Deoxycholic Acid, Monopotassium Salt,Deoxycholic Acid, Monosodium Salt,Deoxycholic Acid, Sodium Salt, 12beta-Isomer,Dihydroxycholanoic Acid,Lagodeoxycholic Acid,Sodium Deoxycholate,12beta-Isomer Deoxycholic Acid,3beta-Isomer Deoxycholic Acid,5alpha-Isomer Deoxycholic Acid,Deoxycholate, Sodium,Deoxycholic Acid, 12beta Isomer,Deoxycholic Acid, 3beta Isomer,Deoxycholic Acid, 5alpha Isomer
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and biological evaluation of dehydroabietic acid-pyrimidine hybrids as antitumor agents.
May 2020, RSC advances,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents.
October 2015, Organic & biomolecular chemistry,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
August 2014, Bioorganic & medicinal chemistry letters,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Correction: Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents.
August 2019, Organic & biomolecular chemistry,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
January 2010, Bioorganic & medicinal chemistry,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
June 2014, European journal of medicinal chemistry,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Revisiting Pyrazolo[3,4-d]pyrimidine Nucleosides as Anti-Trypanosoma cruzi and Antileishmanial Agents.
April 2021, Journal of medicinal chemistry,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
September 2013, European journal of medicinal chemistry,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents.
August 2015, Bioorganic & medicinal chemistry letters,
Kamal Fahmy Mohamed Atta, and Tamer Mohamed Ibrahim, and Omaima Osman Mahmoud Farahat, and Tareq Qasem Al-Shargabi, and Mohamed Gaber Marei, and Adnan Ahmed Bekhit, and El Sayed Helmy El Ashry
Synthesis and biological evaluation of pyrazolo[1,5-a]-pyrimidine-containing 99mTc Nitrido radiopharmaceuticals as imaging agents for tumors.
November 2010, Molecules (Basel, Switzerland),
Copied contents to your clipboard!